大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 4,693 | 4,740 | 4,674 | 4,716 | -22 | -0.5% | 740,900 |
2021/08/18 | 4,730 | 4,774 | 4,722 | 4,738 | +70 | +1.5% | 957,700 |
2021/08/17 | 4,633 | 4,714 | 4,633 | 4,668 | +36 | +0.8% | 620,700 |
2021/08/16 | 4,687 | 4,705 | 4,606 | 4,632 | -54 | -1.2% | 631,600 |
2021/08/13 | 4,712 | 4,780 | 4,654 | 4,686 | +44 | +0.9% | 784,800 |
2021/08/12 | 4,698 | 4,698 | 4,637 | 4,642 | -78 | -1.7% | 645,000 |
2021/08/11 | 4,660 | 4,747 | 4,659 | 4,720 | +88 | +1.9% | 738,100 |
2021/08/10 | 4,445 | 4,665 | 4,438 | 4,632 | +237 | +5.4% | 1,147,700 |
2021/08/06 | 4,335 | 4,452 | 4,330 | 4,395 | +52 | +1.2% | 914,400 |
2021/08/05 | 4,353 | 4,381 | 4,338 | 4,343 | -23 | -0.5% | 394,400 |
2021/08/04 | 4,420 | 4,430 | 4,353 | 4,366 | -35 | -0.8% | 528,900 |
2021/08/03 | 4,405 | 4,436 | 4,391 | 4,401 | -71 | -1.6% | 497,100 |
2021/08/02 | 4,400 | 4,487 | 4,391 | 4,472 | +134 | +3.1% | 737,700 |
2021/07/30 | 4,443 | 4,448 | 4,338 | 4,338 | -123 | -2.8% | 663,600 |
2021/07/29 | 4,493 | 4,517 | 4,446 | 4,461 | -10 | -0.2% | 665,500 |
2021/07/28 | 4,478 | 4,483 | 4,453 | 4,471 | -16 | -0.4% | 408,600 |
2021/07/27 | 4,513 | 4,527 | 4,472 | 4,487 | -19 | -0.4% | 467,500 |
2021/07/26 | 4,570 | 4,570 | 4,477 | 4,506 | +41 | +0.9% | 571,300 |
2021/07/21 | 4,486 | 4,514 | 4,451 | 4,465 | +29 | +0.7% | 432,300 |
2021/07/20 | 4,438 | 4,470 | 4,404 | 4,436 | -39 | -0.9% | 618,500 |
2021/07/19 | 4,485 | 4,485 | 4,427 | 4,475 | -10 | -0.2% | 587,100 |
2021/07/16 | 4,468 | 4,519 | 4,441 | 4,485 | +6 | +0.1% | 790,900 |
2021/07/15 | 4,481 | 4,566 | 4,473 | 4,479 | -72 | -1.6% | 870,600 |
2021/07/14 | 4,487 | 4,580 | 4,480 | 4,551 | +64 | +1.4% | 1,018,100 |
2021/07/13 | 4,430 | 4,509 | 4,411 | 4,487 | +97 | +2.2% | 922,400 |
2021/07/12 | 4,415 | 4,420 | 4,347 | 4,390 | +86 | +2% | 1,070,400 |
2021/07/09 | 4,275 | 4,312 | 4,226 | 4,304 | +5 | +0.1% | 1,768,500 |
2021/07/08 | 4,365 | 4,373 | 4,279 | 4,299 | -201 | -4.5% | 2,418,700 |
2021/07/07 | 4,475 | 4,505 | 4,427 | 4,500 | -41 | -0.9% | 844,500 |
2021/07/06 | 4,552 | 4,583 | 4,506 | 4,541 | +2 | ±0% | 739,700 |
2021/07/05 | 4,563 | 4,591 | 4,535 | 4,539 | -31 | -0.7% | 546,300 |
2021/07/02 | 4,625 | 4,644 | 4,550 | 4,570 | -42 | -0.9% | 598,700 |
2021/07/01 | 4,600 | 4,637 | 4,577 | 4,612 | +5 | +0.1% | 636,800 |
2021/06/30 | 4,677 | 4,677 | 4,601 | 4,607 | -31 | -0.7% | 707,300 |
2021/06/29 | 4,667 | 4,667 | 4,595 | 4,638 | -92 | -1.9% | 906,700 |
2021/06/28 | 4,770 | 4,770 | 4,692 | 4,730 | -9 | -0.2% | 736,400 |
2021/06/25 | 4,752 | 4,774 | 4,719 | 4,739 | +10 | +0.2% | 583,900 |
2021/06/24 | 4,701 | 4,738 | 4,678 | 4,729 | -4 | -0.1% | 609,600 |
2021/06/23 | 4,747 | 4,793 | 4,723 | 4,733 | -15 | -0.3% | 658,700 |
2021/06/22 | 4,646 | 4,764 | 4,619 | 4,748 | +193 | +4.2% | 1,172,500 |
2021/06/21 | 4,564 | 4,581 | 4,512 | 4,555 | -149 | -3.2% | 1,023,700 |
2021/06/18 | 4,713 | 4,723 | 4,673 | 4,704 | +20 | +0.4% | 1,416,300 |
2021/06/17 | 4,757 | 4,774 | 4,666 | 4,684 | -73 | -1.5% | 759,900 |
2021/06/16 | 4,794 | 4,806 | 4,742 | 4,757 | -33 | -0.7% | 757,400 |
2021/06/15 | 4,750 | 4,801 | 4,731 | 4,790 | +37 | +0.8% | 701,400 |
2021/06/14 | 4,750 | 4,759 | 4,719 | 4,753 | +23 | +0.5% | 601,600 |
2021/06/11 | 4,696 | 4,747 | 4,670 | 4,730 | +35 | +0.7% | 1,125,500 |
2021/06/10 | 4,625 | 4,707 | 4,623 | 4,695 | +44 | +0.9% | 746,300 |
2021/06/09 | 4,670 | 4,678 | 4,617 | 4,651 | -2 | ±0% | 536,800 |
2021/06/08 | 4,650 | 4,672 | 4,600 | 4,653 | +52 | +1.1% | 880,900 |
801~
850
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム